Doctor profile · Federal record
Dr. Matthew Cassell, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Specialist · Meridian, MS
- NPI 1427269331
- Accepts Medicare
- MIPS 98.6 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1704 23Rd Ave, Second Floor
Meridian, MS 393013103
(601) 482-1555
fax (601) 696-4608
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- October 15, 2024
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Mississippi #20329
- Medicaid
- MS #009300810
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427269331. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
84,741
Distinct HCPCS
10
Medicare allowed
$1,629,073
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 30,090 | 23 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,400 | 12 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 13,380 | 37 | $23 | |
J1449 |
Injection, eflapegrastim-xnst, 0.1 mg | 7,392 | 20 | $32 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 5,750 | 65 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 3,960 | 52 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,275 | 423 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 1,117 | 393 | $10 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,108 | 375 | $8 | |
J9190 |
Injection, fluorouracil, 500 mg | 990 | 15 | $2 |
In context: peer comparison
Among 2 peers in Meridian Hematology & Oncology Physician, average services per provider: 1,643. This provider delivers 52× the peer median.Open Payments
Industry payments received
All-time total
$4,817
Transactions
120
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $1,463.24 | |
| Janssen Biotech, INC. | 12 | $353.58 | |
| AstraZeneca Pharmaceuticals Lp | 11 | $315.18 | |
| Incyte Corporation | 8 | $228.03 | |
| Merck Sharp & Dohme LLC | 10 | $224.32 | |
| Genzyme Corporation | 4 | $198.25 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $185.43 | |
| Pfizer INC. | 7 | $141.65 | |
| Aveo Pharmaceuticals, INC. | 2 | $118.10 | |
| Celgene Corporation | 5 | $110.56 | |
| Gilead Sciences, INC. | 4 | $108.66 | |
| Genentech USA, INC. | 5 | $98.02 | |
| Lilly USA, LLC | 4 | $89.47 | |
| Astellas Pharma US INC | 4 | $87.21 | |
| GlaxoSmithKline, LLC. | 5 | $85.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
591
Patients
138
Total drug cost
$1,625,580
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 108 | 35 | $2,542 |
| Ondansetron Hcl | Generic | 69 | 37 | $792 |
| Tramadol Hcl | Generic | 67 | 12 | $482 |
| Tamoxifen Citrate | Generic | 59 | 19 | $1,566 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 42 | 20 | $1,410 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 42 | 0 | $1,381 |
| Pomalyst (Pomalidomide) | Brand | 32 | 0 | $595,283 |
| Prednisone | Generic | 31 | 15 | $97 |
| Revlimid (Lenalidomide) | Brand | 25 | 0 | $457,565 |
| Imbruvica (Ibrutinib) | Brand | 24 | 0 | $399,548 |
Hospital affiliations
Frequently asked questions
What is Dr. Matthew Cassell's medical specialty?
Dr. Matthew Cassell practices Hematology & Oncology Physician in Meridian, MS.
Where does Dr. Matthew Cassell practice?
Dr. Matthew Cassell practices at 1704 23Rd Ave, Meridian, MS 393013103. Office phone: 6014821555.
What is Dr. Matthew Cassell's NPI?
Dr. Matthew Cassell's National Provider Identifier (NPI) is 1427269331, issued by NPPES.
Does Dr. Matthew Cassell accept Medicare assignment?
Yes. Dr. Matthew Cassell accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Cassell commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.